Multiple biochemical deficits in both gray and white matter of Alzheimer brains
- PMID: 3797685
- DOI: 10.1016/0278-5846(86)90014-x
Multiple biochemical deficits in both gray and white matter of Alzheimer brains
Abstract
A biochemical investigation of 21 brains from patients with dementia of Alzheimer type (AD/SDAT) and 22 brains from controls was made. In the normal brains 5-hydroxytryptamine (5-HT), noradrenaline (NA) and dopamine (DA) were reduced with age while their metabolites were not reduced. In the brains from the Alzheimer patients the examination of gray matter (caudate nucleus and hippocampus) showed a significant reduced activity of choline-acetyl transferase (CAT) and a reduction of acetylcholinesterase (AChE) that bordered significance in the hippocampus. In the brains from the Alzheimer patients a disturbance was found in the 5-HT system in the form of reduced levels of 5-HT and 5-hydroxyindolacetic acid (5-HIAA). The catecholamine systems were also disturbed but to a less extent. In the 5-HT and DA systems the active amines as well as the metabolites were reduced in the brains from patients with AD/SDAT indicating not only a possible neuronal loss but also an incapacity of the remaining neurons to compensate for the loss by an increased turnover. The lipid content was slightly reduced in gray matter of the demented brains. In white matter there was a more severe reduction of the lipids and in this tissue also the cerebrosides and sulfatides were reduced. It is concluded that in brains from patients with AD/SDAT there are multiple biochemical deficits in gray as well as in white matter. The changes in white matter may be of pathogenetic importance in subgroups of AD/SDAT.
Similar articles
-
Alzheimer's disease and senile dementia: biochemical characteristics and aspects of treatment.Psychopharmacology (Berl). 1985;86(3):245-52. doi: 10.1007/BF00432208. Psychopharmacology (Berl). 1985. PMID: 2863836 Review.
-
Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT).Neurobiol Aging. 1983 Winter;4(4):261-71. doi: 10.1016/0197-4580(83)90002-7. Neurobiol Aging. 1983. PMID: 6200784
-
Neurochemical aspects on aging and diseases with cognitive impairment.J Neurosci Res. 1990 Dec;27(4):541-7. doi: 10.1002/jnr.490270415. J Neurosci Res. 1990. PMID: 2079715 Review.
-
A post-mortem study of noradrenergic, serotonergic and GABAergic neurons in Alzheimer's disease.J Neurol Sci. 1988 Mar;84(1):101-16. doi: 10.1016/0022-510x(88)90179-7. J Neurol Sci. 1988. PMID: 2452858
-
Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.Ann Neurol. 1992 Jun;31(6):611-20. doi: 10.1002/ana.410310608. Ann Neurol. 1992. PMID: 1355334
Cited by
-
COVID-19 and Alzheimer's Disease Share Common Neurological and Ophthalmological Manifestations: A Bidirectional Risk in the Post-Pandemic Future.Cells. 2023 Nov 10;12(22):2601. doi: 10.3390/cells12222601. Cells. 2023. PMID: 37998336 Free PMC article. Review.
-
Poorer aging trajectories are associated with elevated serotonin synthesis capacity.Mol Psychiatry. 2023 Oct;28(10):4390-4398. doi: 10.1038/s41380-023-02177-x. Epub 2023 Jul 17. Mol Psychiatry. 2023. PMID: 37460847 Free PMC article.
-
Monoaminergic neuropathology in Alzheimer's disease.Prog Neurobiol. 2017 Apr;151:101-138. doi: 10.1016/j.pneurobio.2016.04.001. Epub 2016 Apr 12. Prog Neurobiol. 2017. PMID: 27084356 Free PMC article. Review.
-
Antioxidant capacity in the lipophilic fraction of Alzheimer's brain tissues.Bosn J Basic Med Sci. 2007 Nov;7(4):317-21. doi: 10.17305/bjbms.2007.3020. Bosn J Basic Med Sci. 2007. PMID: 18039189 Free PMC article.
-
Age-related behavioural, neurochemical and radioligand binding changes in the central 5-HT system of Sprague-Dawley rats.Psychopharmacology (Berl). 1993;113(2):274-81. doi: 10.1007/BF02245710. Psychopharmacology (Berl). 1993. PMID: 7531851
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous